EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Role of α‐SMA, NOX4, Fibronectin, and HIF‐1α in Pulmonary Microvascular Remodeling in COPD Patients Without Pulmonary Arterial Hypertension

Guo Xiaotong, Fan Yuchun, Ji Ting, Cao Xia, Jiang Haifeng, Chen Juan iD, Xin Hongxia iD

The Clinical Respiratory Journal · 2026

DOI: 10.1111/crj.70218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2026. Verfasst von Guo Xiaotong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The General Hospital of Ningxia Medical University, Yinchuan, China. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Pulmonary Disease, Chronic Obstructive, Fibronectins, NADPH Oxidase 4. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science Foundation of Ningxia Hui Autonomous Region, Ningxia Medical University Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary arterial hypertension (PAH) is a severe chronic obstructive pulmonary disease (COPD) complication, with vascular remodeling occurring early in disease progression. Oxidative stress, particularly NADPH oxidase subunit 4 (NOX4) activity, drives vascular smooth muscle differentiation, vasoconstriction, and proliferation, while Hypoxia‐inducible factor‐1α (HIF‐1α), activated by NOX4‐derived hydrogen peroxide (H 2 O 2 ), plays a key contributory role in early pulmonary vascular remodeling. This study explores the roles of α‐smooth muscle actin (α‐SMA), NOX4, fibronectin (FN), and HIF‐1α roles in pulmonary microvascular remodeling in COPD patients without PAH.

Methods

Lung tissue samples from patients undergoing resection at General Hospital of Ningxia Medical University (Oct 2022–Dec 2023) were analyzed. Participants included COPD ( n = 20) and control ( n = 17) groups. NOX4, HIF‐1α, α‐SMA, and fibronectin expression in the pulmonary microvasculature (< 500 μm) were assessed via immunohistochemistry and Western blot. Smooth muscle remodeling (pulmonary vascular smooth muscle thickness percentage, WT%; pulmonary vascular smooth muscle area percentage, WA%) and serum vascular endothelial growth factor (VEGF) levels were evaluated.

Results

COPD patients exhibited significant thickening of the pulmonary microvascular smooth muscle layer, with endothelial cell swelling, degeneration, and necrosis. The WT% and WA% values of COPD patients were elevated compared to controls, alongside increased FN expression in the pulmonary microvasculature. NOX4, HIF‐1α, and α‐SMA expression levels were higher in COPD patients, particularly within endothelial cells and macrophages surrounding pulmonary vessels. The peripheral blood neutrophil count in the COPD group was higher than in the control group. Compared to the control group, COPD patients showed high expression of NOX4 and HIF‐1α in macrophages surrounding the pulmonary microvessels. Serum VEGF concentrations were significantly elevated in COPD patients and positively correlated with HIF‐1α expression in lung tissue homogenates.

Conclusions

Pulmonary microvascular remodeling occurs in COPD patients even without PAH, characterized by smooth muscle thickening, extracellular matrix deposition, and endothelial alterations. The NOX4‐HIF‐1α oxidative stress pathway, coupled with inflammatory cell activation, may contribute to microvascular remodeling in COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Inducible Factor 1, alpha SubunitPulmonary Disease, Chronic ObstructiveFibronectinsNADPH Oxidase 4ActinsVascular RemodelingHumansMaleFemaleMiddle AgedAgedOxidative StressMuscle, Smooth, VascularLungMicrovesselsVascular Endothelial Growth Factor AHypertension, Pulmonary

Stichwörter der Autor:innen

HIF‐1αNOX4chronic obstructive pulmonary diseaseextracellular matrixpulmonary microvesselspulmonary vascular remodeling

Substanzen

Hypoxia-Inducible Factor 1, alpha SubunitFibronectinsNADPH Oxidase 4ActinsHIF1A protein, humanNOX4 protein, humanACTA2 protein, humanVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, The General Hospital of Ningxia Medical University, Yinchuan, China.
  • Department of Pathology, The General Hospital of Ningxia Medical University, Yinchuan, China.

ORCID-Profile: Chen Juan, Xin Hongxia

Förderung

  • National Natural Science Foundation of China
  • Science Foundation of Ningxia Hui Autonomous Region
  • Ningxia Medical University Scientific Research Project

Zitieren

APA

Xiaotong, G., Yuchun, F., Ting, J., Xia, C., Haifeng, J., Juan, C., & Hongxia, X. (2026). Role of α‐SMA, NOX4, Fibronectin, and HIF‐1α in Pulmonary Microvascular Remodeling in COPD Patients Without Pulmonary Arterial Hypertension. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70218

Vancouver

Xiaotong G, Yuchun F, Ting J, Xia C, Haifeng J, Juan C, et al. Role of α‐SMA, NOX4, Fibronectin, and HIF‐1α in Pulmonary Microvascular Remodeling in COPD Patients Without Pulmonary Arterial Hypertension. The Clinical Respiratory Journal. 2026. doi:10.1111/crj.70218

BibTeX
@article{Xiaotong2026,
  author = {Xiaotong, Guo and Yuchun, Fan and Ting, Ji and Xia, Cao and Haifeng, Jiang and Juan, Chen and Hongxia, Xin},
  title = {Role of α‐SMA, NOX4, Fibronectin, and HIF‐1α in Pulmonary Microvascular Remodeling in COPD Patients Without Pulmonary Arterial Hypertension},
  journal = {The Clinical Respiratory Journal},
  year = {2026},
  doi = {10.1111/crj.70218}
}
Kostenlos starten →